Search Results (149,428)

Background/Objectives: Moderate aortic stenosis (AS) with preserved ejection fraction (EF) is common, yet risk stratification remains challenging. Cardiopulmonary exercise testing (CPET) and myocardial mechanics analysis may identify subclinical dysfunction and impaired functional capacity. To evaluate the relationship between functional capacity (by % predicted peak VO₂), ventilatory efficiency (VE/VCO₂ slope), and myocardial mechanics (speckle tracking echocardiography—STE), and myocardial work (MW) indices) in moderate AS with preserved EF. Methods: We prospectively enrolled 107 patients with moderate AS (AVA 1.0–1.5 cm²; mean gradient 20–40 mmHg; EF ≥ 50%). Functional capacity was classified as preserved (≥83% predicted VO₂) or reduced (<83%). Ventilatory efficiency was defined as good (<30) or poor (≥30) VE/VCO₂ slope. STE assessed left ventricular (LV), left atrial (LA), and right ventricular (RV) strain, as well as myocardial work indices. Results: Patients with reduced % predicted VO₂ had higher LV end-systolic volume (p = 0.035), lower stroke volume index (p = 0.020), and smaller indexed aortic valve area (p = 0.025), with trends toward lower GLS and myocardial work. In contrast, patients with poor ventilatory efficiency (VE/VCO₂ ≥ 30) showed significant impairments in global longitudinal strain (GLS, p = 0.002), LA reservoir strain (PALS, p = 0.019) and LA conduit strain (LA Scd, p < 0.001), RV free wall strain (RW FWS, p = 0.029), and myocardial work indices (lower GWI and GCW, higher GWW, reduced GWE; all p < 0.05). LA Scd emerged as the strongest predictor of poor ventilatory efficiency. (receiver operating characteristic (ROC) area under the curve (AUC) 0.723, 95% confidence interval (CI) 0.623–0.823, p < 0.001). Conclusions: In moderate AS with preserved EF, impaired ventilatory efficiency is more strongly associated with subclinical LV, LA, and RV dysfunction than reduced % predicted VO₂, highlighting the key role of RV impairment. Integrating CPET and STE improves phenotyping, identifying high-risk patients who may benefit from closer surveillance or early intervention. These findings are exploratory and hypothesis-generating; longitudinal data are needed to confirm prognostic implications. Full article

Background/Objectives: Rigid bronchoscopy poses safety challenges due to airway leakage. Although apnoeic oxygenation is a potential strategy, concerns over carbon dioxide (CO₂) retention have limited its adoption. The introduction of high-flow nasal cannula (HFNC) has renewed interest by potentially mitigating CO₂ accumulation during prolonged apnoea. This study investigated changes in the arterial partial pressure of CO₂ (PaCO₂) during apnoeic oxygenation using Optiflow™. Methods: We retrospectively analysed patients undergoing rigid bronchoscopy with HFNC (70 L·min⁻¹) from 2020 to 2022. The apnoeic period was defined from the onset of apnoeic oxygenation to ventilation resumption. Arterial blood gas levels and complications, including arrhythmia and desaturation, were evaluated. Regression analysis was used to evaluate changes over time. Results: Apnoeic oxygenation was performed in 10 male patients (mean age 65 ± 14 years; body mass index 24.75 ± 4.18 kg·m⁻²). The mean duration of apnoea was 33.7 ± 13.7 min, with PaCO₂ rising linearly at 1.50 mmHg/min. No interventions were required to maintain SpO₂ above 91% for all patients. Except for one case of atrial fibrillation that occurred during emergence rather than the apnoeic period, no significant complications were observed. Conclusions: The observed increase in PaCO₂ was lower than in previously reported studies using HFNC via the nares, suggesting that direct delivery of oxygen to the distal airway via bronchoscopy may enhance CO₂ clearance through more effective washout. Apnoeic oxygenation with HFNC could potentially overcome airway leakage for selected patients, but vigilant monitoring remains essential throughout the apnoeic period. Further research is warranted to enhance patient safety. Full article

Background/Objectives: Evaluate outcomes and treatment patterns with 2 mg intravitreal aflibercept injection among patients who completed the phase 3 PANORAMA trial and enrolled in the VOYAGE (ClinicalTrials.gov identifier, NCT04708145; 12 January 2021) long-term extension study. Methods: During VOYAGE, patients were evaluated every 16 weeks and treated with 2 mg intravitreal aflibercept injection as needed depending on ophthalmoscopic examination findings. Those with no history of panretinal photocoagulation (PRP) received aflibercept if their clinician-determined diabetic retinopathy severity scale (DRSS) level was ≥47. Patients with a history of PRP received aflibercept if active neovascularization was present. New or worsening diabetic retinopathy (DR) severity prompted more frequent treatment. Results: 320 patients (1 eye per patient) from 87 sites completed the PANORAMA trial. Of these, 41 patients (13% of PANORAMA completers) from 14 sites (16%) enrolled in VOYAGE after a mean interim period of 33.7 months, and 35 patients (85%) completed study visits through 1 year. At year 1 in VOYAGE, the mean number of anti-vascular endothelial growth factor (VEGF) injections increased from 1.1 per year during the interim period to 3.4 per year and was associated with stabilization or improvement in DRSS level in 81% (26/32) of patients. Mean best-corrected visual acuity (BCVA) remained relatively stable, and mean central subfield thickness (CST) improved by 24.4 µm to 269.5 μm through year 1 of VOYAGE. There were no unexpected safety events. Conclusions: Following a mean of 3 years of routine clinical care with associated declines in DRSS level, CST, and BCVA, stabilization of DRSS level and BCVA with reductions in CST was achieved through year 1 of the VOYAGE extension study, with a concurrent increase in aflibercept dosing frequency. Full article

Background/Objectives: Treatment planning for stage III non–small cell lung cancer (NSCLC) presents dosimetric challenges due to the proximity of critical structures. RapidPlan (RP), a knowledge-based planning (KBP) system, offers the potential for improved plan consistency and organ-at-risk (OAR) sparing. The objective of this study was to compare dosimetric and clinical outcomes of RP-generated plans versus manually optimized plans in patients with stage III NSCLC undergoing IMRT or VMAT. Methods: In this retrospective analysis, 50 patients treated with concurrent chemoradiation for stage III NSCLC at Hadassah Medical Center (2015–2021) were analyzed. RP plans were generated using a lung-specific model in the Eclipse treatment planning system and compared with the original clinical manual plans. Dosimetric parameters for target volumes and OARs were evaluated, and subgroup analyses were performed by technique (IMRT vs. VMAT). Toxicity and survival outcomes were analyzed, and Normal Tissue Complication Probability (NTCP) modeling was conducted. Results: RP significantly reduced mean heart dose (Δ = −2.54 Gy, p < 0.001), spinal cord maximum dose (Δ = −4.08 Gy, p < 0.001), and esophageal mean dose (Δ = −3.89 Gy, p < 0.001) compared with manual plans. Lung doses were slightly higher in RP plans (V20 Δ = +2.12%, p < 0.001). VMAT-RP plans demonstrated greater cardiac and esophageal sparing than VMAT-manual plans. RP yielded significant NTCP reductions for the heart (0.34% → 0.20%) and esophagus (16.6% → 11.5%), but no improvement for lung or spinal cord. Lung toxicity ≥ grade 2 was associated with reduced overall survival (16.2 vs. 51.8 months, p < 0.001). Conclusions: RapidPlan-based knowledge-based planning enhances OAR sparing while maintaining target coverage in locally advanced NSCLC. Slight increases in lung dose highlight the need for ongoing model refinement. An association between lung toxicity and reduced survival was observed, underscoring the impact of treatment-related morbidity on outcomes. Full article

Background: Few trials have evaluated liquid chromatography–mass spectrometry (LC–MS)–standardized ready-to-drink formulations, and short-term responses of composite lipid–glucose indices under controlled intake remain unquantified. This study assessed 8-week changes in Atherogenic and triglyceride–glucose indices (AIP and TyG) after the consumption of a Hibiscus–inulin (HIB–INU) beverage and tested whether baseline risk modified these effects. Methods: A randomized, double-blind, placebo-controlled trial was conducted in adults aged 18–50 years with BMI ≥ 25 kg/m² (n = 100: 50 per group) who consumed a daily 60 mL Hibiscus–inulin shot or sensory-matched placebo for 8 weeks. The Hibiscus–inulin shot was LC–MS–standardized to ensure reproducible exposure; co-primary outcomes were AIP and TyG (pre-specified as exploratory), and secondary outcomes were mean arterial pressure (MAP) and pulse pressure (PP). ANCOVA adjusted for baseline, age, and sex was used to estimate between-group differences and to test for interactions by baseline risk. Results: Adjusted 8-week differences versus placebo were −0.09 for AIP (95% CI −0.15 to −0.03; p = 0.004) and −0.14 for TyG (−0.26 to −0.03; p = 0.020). MAP and PP showed no significant differences between the groups (p > 0.05). Effects were larger in high-risk baseline strata. Conclusions: A standardized hibiscus–inulin shot produced short-term improvements in composite lipid–glucose indices without hemodynamic change. Because minimal clinically important differences for AIP/TyG have not been established for short durations, these findings reflect analytical responsiveness rather than clinical benefits, supporting their exploratory use in short-term nutrition trials and cardiometabolic monitoring. Full article

Mild cognitive impairment (MCI) represents a heterogeneous state between normal aging and dementia, with varied transition pathways. While factors influencing MCI progression are known, their role in cognitive reversal is unclear. This study analyzed 756 Alzheimer’s Disease Neuroimaging Initiative (ADNI) participants, classified as progressive MCI (pMCI, N = 272, mean age = 75.10 ± 7.34 years), reversible MCI (rMCI, N = 52, mean age = 69.94 ± 7.98 years) and stable MCI (sMCI, N = 432, mean age = 73.34 ± 7.44 years) based on 36-month follow-up. We compared demographic, lifestyle, clinical, cognitive, neuroimaging, and biomarker data across groups and developed a prediction model. Patients in the rMCI group were significantly younger and had a higher level of education compared with those in the pMCI group. Memory, general cognition, daily functional activities, and hippocampal volume effectively distinguished all three groups. In contrast, Aβ, tau, and other brain regions were able to distinguish only between progressive and non-progressive cases. Informant-reported Everyday Cognition (Ecog) scales outperformed self-reported Ecog scales in differentiating subtypes and predicting progression. Multinomial regression revealed that higher education, larger hippocampal volume, and lower daily functional impairment were associated with reversion, whereas APOE ε4, poorer memory, and greater brain atrophy predicted progression (model accuracy: 78%). The results confirm the significant utility of hippocampal volume, education level, and daily functional activities for assessing baseline disparities and predicting reversion. This study highlights the differential contributions of cognitive abilities and brain regions on MCI reversal, advancing understanding of MCI heterogeneity and providing evidence for precise diagnosis and treatment in early MCI. Full article

Pavement texture is a crucial factor influencing both skid resistance and durability. This study aims to investigate the impact of texture reconstruction on pavement performance, which holds significant scientific value for enhancing road safety and durability. The research focuses on the reconstruction of airport cement pavement textures through the design of seven solid–liquid, two-component coating formulations, comprising three types of coatings: emulsion coating (P), waterborne epoxy coating (E), and water-based coating (W). Laser texture scanning technology was employed to identify the texture characteristics, which, combined with the British pendulum test, enabled a comprehensive analysis of skid resistance. Additionally, the coating–concrete interfacial strength and frost resistance were evaluated through pull-out tests, flexural strength tests, and freeze–thaw cycle tests. The results demonstrated that, compared to uncoated concrete, the mean profile depth (MPD) of the P, E, and W coatings increased by 43.4%, 34.7%, and 21.6%, respectively. Furthermore, the peak band of the slope spectrum density (SSD) shifted from a range greater than 1 mm to approximately 0.5 mm following coating application. The British pendulum number (BPN) increased by 25%, 20%, and 15% for the P, E and W coatings, demonstrating a strong correlation with MPD (R² = 0.95). These results indicate that the coated surface texture exhibits superior properties, which explain the enhanced slip resistance from a textural perspective. Moreover, the interfacial strength between the coating and concrete initially increased and then decreased with increasing coating thickness. In comparison, the interfacial bonding strength of the E coating was significantly higher than that of the P and W coatings. Furthermore, compared to the P and W coatings, the flexural bond strength of the E coating increased by 7% and 74%, respectively. After undergoing the freeze–thaw cycle, the E coating exhibited the best freeze resistance, while the W coating exhibited the poorest performance. In summary, the P coating excelled in texture reconstruction, while the E coating provided superior bonding and freeze resistance. This paper presents a novel approach to the development of coating materials for use on airport pavements. Full article

Background: Chronotype refers to an individual’s preferred timing of activity and rest within a 24-h period, reflecting behavioral manifestations of the endogenous circadian rhythm. Variations in circadian timing may contribute to the temporal characteristics and pathophysiology of tension-type headache (TTH). TTH is the most common primary headache disorder and can have a significant impact on quality of life. While chronotype has been shown to influence pain perception, mood, and sleep quality in various chronic pain conditions, its relationship to TTH remains insufficiently explored. Aim: We aimed to determine the distribution of chronotypes among patients with TTH and to assess their associations with pain characteristics, depression, sleep quality, and quality of life. Methods: This cross-sectional study involved 77 adult patients diagnosed with TTH according to the International Classification of Headache Disorders (ICHD)-III criteria. Patients were recruited from the neurology outpatient clinic at SANKO University Hospital between June 2021 and June 2022. Data were collected using the Morningness–Eveningness Questionnaire (MEQ), the Visual Analogue Scale (VAS), the Hospital Anxiety and Depression Scale (HADS), the Pittsburgh Sleep Quality Index (PSQI), and the Short Form-36 (SF-36). Chronotypes were categorized as morning, intermediate, or evening. Group differences were analyzed using ANOVA, Kruskal–Wallis and linear regression models. Results: The mean age of the study sample was 29.0 [24.0–35.0] years. Fifty-five participants (71.4%) had an intermediate chronotype, 14 (18.2%) had a morning chronotype, and 8 (10.4%) had an evening chronotype. Those with an evening chronotype had a significantly lower BMI than those with an intermediate chronotype (p = 0.035) and lower scores on the SF-36 Role Limitations due to Physical Problems domain than those with a morning chronotype (p = 0.039). Chronotype (as assessed by the MEQ) was negatively correlated with sleep quality, with evening chronotypes showing poorer PSQI scores. No significant differences were found in VAS (pain intensity) and HADS (depression) scores among chronotypes. Linear regression analyses indicated that chronotype significantly predicted SF-36 Bodily Pain scores, whereas sex significantly predicted VAS pain intensity (p = 0.001). Conclusions: Evening chronotype is associated with poorer sleep quality and greater role limitations due to physical problemsin patients with TTH, which can potentially exacerbate the disabilities associated with headaches. Tailored interventions targeting chronotype and sleep may improve quality of life in this population. Full article

Background: Several sarcoidosis patients require treatment with corticosteroids to prevent organ damage and control symptoms. However, corticosteroids are associated with numerous side effects and can be detrimental to patients if used long-term. Roflumilast is approved for the treatment of chronic obstructive pulmonary disease (COPD) and has been studied with positive results in patients with fibrosing sarcoidosis. Due to its mode of action, it targets proinflammatory and profibrotic pathways involved in sarcoidosis and could be a suitable medication for sarcoidosis. Methods: We retrospectively analyzed a cohort of 51 sarcoidosis patients treated with Roflumilast off-label between 2010 and 2020 at the Department of Pneumology, University Hospital Freiburg. Medical records, lung function, and laboratory results were reviewed. Results: Of the 51 patients, 33 patients received Roflumilast for at least 6 months, whereas 18 discontinued treatment, mostly due to mild to moderate gastrointestinal side effects (n = 7). No severe adverse events were observed. Patients on Roflumilast were less likely to have a decrease in FEV1 of more than 10% of their mean FEV1 compared to patients without Roflumilast (OR = 0.2; 95% CI 0.08–0.5). Escalation of therapy was documented in 49/97 (51%) of ambulatory visits for patients taking Roflumilast compared to 100/144 (69%) for patients without Roflumilast (OR = 0.45; 95% CI 0.26–0.76). Conclusions: Sarcoidosis patients receiving Roflumilast had less lung function loss and were less likely to require therapy escalation. Roflumilast could be a therapeutic option in sarcoidosis. Full article

Introduction: Breast cancer is a heterogeneous malignancy influenced by diverse molecular profiles. The L-type amino acid transporter 1 (LAT1), encoded by the SLC7A5 gene, plays a key role in tumor metabolism, growth, and angiogenesis. Through its role in amino acid transport and activation of the mTORC1 signaling pathway, LAT1 has emerged as a potential therapeutic target. Objective: To evaluate SLC7A5/LAT1 expression and its association with clinicopathological parameters and molecular subtypes of invasive carcinoma of no special type (NST) in a Pakistani cohort. Methods: Eighty-three patients who underwent mastectomy or modified radical mastectomy for histologically confirmed primary invasive carcinoma of no special type were included. Immunohistochemistry was used to assess SLC7A5/LAT1 expression. Associations with clinicopathological features and molecular groups were analyzed using the Chi-square test. Results: The mean age of SLC7A5-positive patients were 48.4 ± 10.8 years. Overall, 24.1% of patients demonstrated SLC7A5 positivity. Although SLC7A5 expression was more frequent in cases categorized as having moderate or poor prognosis based on the Nottingham Prognostic Index (NPI), this trend was not statistically significant. Similarly, no significant associations were observed between SLC7A5 expression and other clinicopathological or molecular variables. Conclusions:SLC7A5/LAT1 expression was identified in approximately one-quarter of invasive breast carcinoma cases. Its expression appeared more common in tumors with poorer NPI categories, but without statistically verified associations. These findings suggest that SLC7A5 may act independently of conventional clinicopathological parameters. Larger, longitudinal studies with survival follow-up are required to clarify its prognostic and therapeutic significance. Full article

Background: Morphological subclassification may refine prognosis after curative pancreaticoduodenectomy (PD) for periampullary cancers. Methods: We conducted a single-center retrospective cohort including 120 consecutive PDs performed between 2005 and 2022. Tumors were classified as intestinal (INT), pancreatobiliary (PB), or pancreatic ductal adenocarcinoma (PAN). Clinicopathologic variables included T stage, margin status, lymphovascular and perineural invasion, and lymph node ratio (LNR; cutoff 0.154 determined by ROC/Youden). Overall survival (OS) was the primary endpoint and was analyzed using Kaplan–Meier with log-rank tests and multivariable Cox regression. Results: INT tumors were associated with earlier T stage, fewer adverse histologic features, and higher R0 resection rates compared with PB and PAN. In multivariable analysis, mortality risk was higher for PB (HR 4.41; 95% CI 1.25–15.53) and PAN (HR 13.96; 95% CI 3.99–48.75) relative to INT. LNR ≥ 0.154 independently predicted worse OS (HR 1.93; 95% CI 1.11–3.35). Mean OS was 108.8 months for INT, 62.0 months for PB, and 22.7 months for PAN (log-rank p < 0.001). Conclusions: Morphological subtype and LNR are independent prognostic factors after PD for periampullary malignancies. Integrating morphology and nodal burden into risk models may improve postoperative stratification and guide adjuvant therapy. Full article

Intake of anthocyanin-rich blackcurrant extract showed muscle fibre-type specific force responses during fatigue development from combined use of voluntary maximal isometric contractions and electrically evoked twitch contractions of the m. quadriceps femoris. In the present exploratory study, we examined the fibre-type specific effects by blackcurrant extract on high-intensity intermittent treadmill running performance to exhaustion. Active males (n = 16, age: 23 ± 3 years, height: 179 ± 5 cm, body mass: 79 ± 3 kg, $\dot{V}$O_2max: 55.3 ± 5.0 mL·kg⁻¹·min⁻¹) completed a fatiguing protocol with 16 voluntary maximal isometric contractions to predict muscle fibre typology. The high-intensity intermittent running protocol was completed twice following a 7-day intake of blackcurrant extract (210 mg anthocyanins per day) and twice following a placebo (PL) in a randomized, double blind, crossover design. Heart rate and lactate were recorded at exhaustion. Data were averaged for each condition. There were no significant correlations between the percentage force decline by the repeated isometric contractions (mean ± SD: 29.3 ± 12.4%) and total and high-intensity running distance. Participants were categorized into a predominant muscle fibre type I (slow-twitch, n = 3 with the lowest isometric force decline: 12 ± 9%) and type II typology (fast-twitch, n = 3 with the highest isometric force decline: 46 ± 10%). Only the individuals with a predominant type I fibre typology improved the total running and high-intensity running distance by 17 ± 12% and 15 ± 11%. At exhaustion, there were no differences between individuals with a type I or II fibre typology for heart rate and lactate. These exploratory results suggest that the ergogenic potential of anthocyanin-rich blackcurrant extract on high-intensity intermittent exercise may depend on muscle fibre type, though larger and more robust studies are needed to confirm this observation. Future work will establish whether our exploratory results contributed to our understanding of the underpinning of inter-individual responses to the intake of anthocyanin-rich nutritional ergogenic aids. Full article

Objective: Existing studies on short-chain fatty acids (SCFAs) and colorectal cancer (CRC) yield contradictory conclusions and are limited to single ethnic groups or sample types. This study aimed to (1) quantify associations between total SCFAs/subtypes (acetate, propionate, butyrate) and CRC/advanced colorectal adenoma (A-CRA) risks; (2) identify modifiers (ethnicity, sample type, intervention); and (3) clarify SCFA–gut microbiota interaction mechanisms via integrative Bayesian meta-analysis and multi-ancestry data integration. Methods: We systematically searched PubMed, Embase, Cochrane Library, and Web of Science (inception to September 2025) using keywords: “Short-chain fatty acids”, “SCFAs”, “Colorectal cancer”, “CRC”, “Gut microbiota”, “Dietary fiber”, and “High-amylose maize starch butyrate”. Eligible studies included 14 peer-reviewed original studies (7 observational, cohort/case–control/cross-sectional; 7 RCTs) covering Europeans, Asians, and African Americans. Inclusion criteria: Quantitative SCFA data (total/≥3 subtypes), clear ethnic grouping, reported CRC/A-CRA risks or intervention outcomes. Exclusion criteria: Reviews, animal/in vitro studies, incomplete data, low-quality studies (Newcastle–Ottawa Scale [NOS] <6 for observational; high Cochrane risk for RCTs), or limited populations (single gender/rare genetics). A Bayesian hierarchical random-effects model quantified effect sizes (Odds Ratio [OR]/Mean Difference [MD], 95% credible intervals [CrI]), with heterogeneity analyzed via multi-ancestry stratification, intervention efficacy, and microbiota interaction analyses (Preferred Reporting Items for Systematic Reviews and Meta-Analyses [PRISMA] 2020; International Prospective Register of Systematic Reviews [PROSPERO]: CRD420251157250). Results: Total SCFAs were negatively associated with CRC (OR = 0.78, 95% CrI: 0.65–0.92) and A-CRA (OR = 0.72, 95% CrI: 0.59–0.87), with butyrate showing the strongest protective effect (CRC: OR = 0.63, 95% CrI: 0.51–0.77). Ethnic heterogeneity was significant: Europeans had the strongest protection (OR = 0.71), Asians had weaker protection (OR = 0.86), and African Americans had the lowest fecal SCFA levels and the highest CRC risk. Fecal SCFAs showed a stronger CRC association than serum/plasma SCFAs (OR = 0.73 vs. 0.85). High-Amylose Maize Starch Butyrate (HAMSB) outperformed traditional fiber in increasing fecal butyrate (MD = 4.2 mmol/L vs. 2.8 mmol/L), and high butyrate-producing bacteria (Clostridium, Roseburia) enhanced SCFA protection (OR = 0.52 in high-abundance groups). Conclusions: SCFAs (especially butyrate) protect against CRC and precancerous lesions, with effects modulated by ethnicity, sample type, and gut microbiota. High-Amylose Maize Starch Butyrate is a priority intervention for high-risk populations (e.g., familial adenomatous polyposis, FAP), and differentiated strategies are needed: 25–30 g/d dietary fiber for Europeans, 20–25 g/d for Asians, and probiotics (Clostridium) for African Americans. Future Perspectives: Expand data on underrepresented groups (African Americans, Latinos), unify SCFA detection methods, and conduct long-term RCTs to validate intervention efficacy and “genetics-microbiota-metabolism” crosstalk—critical for CRC precision prevention. Full article

Contacted liquid fluids, in most cases, have the tendency to directly merge into a single larger fluid to minimize the surface energy. We present an abnormal drop formation process of contacted Cu liquid films with a radius of 101.7 Å or larger on carbon substrates by using molecular dynamics simulations. The formation process consists of consecutive pinch-off and full coalescence stages connected by detachment. The dominant motions of the bridge, away from the center and downward to the substrate, lead to the pinch-off of the initially connected droplets. The motions of the droplets, which are near each other at all times, leads to the repeated contact and full coalescence of the separated droplets. The abnormality is attributed to the competition between the motions of the droplets and the tiny liquid bridge that connects the droplets. The influence of the surface structures of substrates, especially carbon nanotubes, on the formation behavior is discussed by analyzing the mean square displacement, velocity fields, and density and scaling profiles. This study provides guidance for controlling drop formation behavior by regulating the surface structures of carbon substrates. Full article

We introduce and study the shortfall of tail-based entropy (STE), a tail-sensitive risk functional that combines expected shortfall (ES) and tail-based entropy (TE). Beyond the tail mean, STE imposes a rank-dependent penalty on tail variability, thereby capturing both the magnitude and variability of tail risk under extremes. The framework encompasses several shortfall-type measures as special cases, such as Gini shortfall, extended Gini shortfall, shortfall of cumulative residual entropy, shortfall of right-tail deviation, and shortfall of cumulative residual Tsallis entropy. We provide equivalent characterizations of STE, derive sufficient conditions for coherence, and establish monotonicity with respect to tail-variability order. As an application, we investigate STE-based capital allocation, deriving closed-form allocation formulas under elliptical and extended skew-normal distributions, along with several illustrative special cases. Finally, an empirical analysis with insurance company data illustrates the implementation and evaluates the performance of the allocation rule. Full article